Cargando…
Melatonin Synergizes With Mesenchymal Stromal Cells Attenuates Chronic Allograft Vasculopathy
BACKGROUND: Chronic rejection characterized by chronic allograft vasculopathy (CAV) remains a major obstacle to long-term graft survival. Due to multiple complicated mechanisms involved, a novel therapy for CAV remains exploration. Although mesenchymal stromal cells (MSCs) have been ubiquitously app...
Autores principales: | Qin, Ya-fei, Kong, De-jun, Qin, Hong, Zhu, Yang-lin, Li, Guang-ming, Sun, Cheng-lu, Zhao, Yi-ming, Wang, Hong-da, Hao, Jing-peng, Wang, Hao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8116651/ https://www.ncbi.nlm.nih.gov/pubmed/33995416 http://dx.doi.org/10.3389/fimmu.2021.672849 |
Ejemplares similares
-
Corrigendum: Melatonin Synergizes With Mesenchymal Stromal Cells Attenuates Chronic Allograft Vasculopathy
por: Qin, Ya-fei, et al.
Publicado: (2021) -
Extracellular HMGB1 Contributes to the Chronic Cardiac Allograft Vasculopathy/Fibrosis by Modulating TGF-β1 Signaling
por: Zou, Huijuan, et al.
Publicado: (2021) -
Triptolide Attenuates Transplant Vasculopathy Through Multiple Pathways
por: Luo, Zihuan, et al.
Publicado: (2020) -
Structural and Temporal Dynamics of Mesenchymal Stem Cells in Liver Diseases From 2001 to 2021: A Bibliometric Analysis
por: Shao, Bo, et al.
Publicado: (2022) -
Allograft or Recipient ST2 Deficiency Oppositely Affected Cardiac Allograft Vasculopathy via Differentially Altering Immune Cells Infiltration
por: Zhang, Zhenggang, et al.
Publicado: (2021)